European Respiratory Journal
European Respiratory Society · Clinical Medicine · ISSN 0903-1936, 1399-3003
- Impact (2-yr)
- 0.8
- h-index
- 381
- Open access
- 20%
- Works
- 82.2K
- Papers this month
- 50
Rebuilt
Latest in ERJ
Newest first · last 60 days
AI summary · may contain errors
Mitiperstat 5 mg once daily did not improve time to first COPDCompEx event over 24 weeks in adults with moderate-to-severe COPD at high exacerbation risk.
- Open access
- 1 cites
AI summary · may contain errors
A first integrative multiomics atlas of the human LAM niche identifies three LAM CORE subtypes, including a fibroblast-like CORE2 with potent extracellular matrix remodelling activity.
- Open access
- 4 cites
AI summary · may contain errors
Vasculitis in alpha-1 antitrypsin deficiency is linked to a higher prevalence of bronchiectasis, suggesting a distinct airway-focused phenotype in EARCO registry subjects.
- Open access
AI summary · may contain errors
In the PHOSP-COVID UK cohort, the “very severe” cluster with predominantly pulmonary disease is linked to a distinct oral microbiota profile 6 months after discharge.
- Open access
- 1 cites
AI summary · may contain errors
EU-PEARL consensus guidance recommends early regulator engagement and careful IRP design for TB adaptive platform trials, emphasizing decision rules and surrogate markers to support regulatory acceptance.
AI summary · may contain errors
Recombinant BMP3 prevents and reverses pulmonary arterial hypertension in mice, and lung-targeted AAV1-BMP3 overexpression reverses remodeling and improves cardiac function in mice and rats.
- Open access
- 2 cites
AI summary · may contain errors
In 5213 patients with acute pulmonary embolism, major bleeding occurred in 3.1% within 30 days, with 78 early (<7 days) and 81 late (≥7 days) events.
- Open access
AI summary · may contain errors
GINA’s 2026 Strategy Report strengthens personalized, iterative asthma care using the Assess-Adjust-Review cycle to improve symptom control and reduce future risk across the lifespan.
- Open access
AI summary · may contain errors
Hepatopulmonary syndrome and portopulmonary hypertension are distinct pulmonary vascular complications in liver transplantation candidates, and both substantially increase morbidity and mortality.
- Open access
Browse JClub
Journals this month
- bioRxiv6357
- medRxiv1736
- PNAS556
- JAMA352
- Sci Adv330
- Cell Rep314
- Environ Res213
- BMJ209
- EHJ206
- Nat Commun172
- NAR172
- Plant Cell Environ167
- Environ Pollution153
- Science152
- NEJM148
- New Phytol145
- Curr Biol130
- Nature127
Topics moving, week to 17 Nov 2026
- Single-cell and spatial transcriptomics10
- Gut microbiota and health6
- CAR-T cell therapy research6
- Pancreatic and Hepatic Oncology Research5
- Genomics and Chromatin Dynamics5
- Inflammatory Bowel Disease5
- Lung Cancer Treatments and Mutations5
- Antibiotic Resistance in Bacteria5
- Genomics and Phylogenetic Studies4
- Lipoproteins and Cardiovascular Health4
By field
- General Science & Medicine22
- Clinical Medicine25
- Cardiology & Vascular Biology12
- Endocrinology & Metabolism10
- Gastroenterology & Hepatology7
- Public & Global Health4
- Cell & Molecular Biology30
- Immunology & Inflammation14
- Neuroscience14
- Psychiatry & Mental Health8
- Genomics & Bioinformatics29
- Pharmacology & Drug Discovery5
- Microbiology & Mycology34
- Oncology22
- Ecology & Evolution5
- Protected Cropping & Horticultural Science5
- Plant Physiology & Photobiology19
- Student Research1
